ticker,event_date,window_start,window_end,symbol,symbols,publishedDate,publishedDateET,date_et,title,text,site,url,image
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-21 13:14:41,2022-07-21T13:14:41-04:00,2022-07-21,Healthcare ETFs in Focus Ahead of Q2 Earnings,"The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.",zacks.com,https://www.zacks.com/stock/news/1955879/healthcare-etfs-in-focus-ahead-of-q2-earnings,https://images.financialmodelingprep.com/news/healthcare-etfs-in-focus-ahead-of-q2-earnings-20220721.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-21 12:00:01,2022-07-21T12:00:01-04:00,2022-07-21,Red-Hot Eli Lilly Stock Has Room to Run,Schaeffer's Investment Research was built from scratch on Bernie Schaeffer's vision of providing accessible professional-grade trading information to retail traders.,schaeffersresearch.com,https://www.schaeffersresearch.com/content/analysis/2022/07/21/red-hot-eli-lilly-stock-has-room-to-run,https://images.financialmodelingprep.com/news/redhot-eli-lilly-stock-has-room-to-run-20220721.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-22 16:58:58,2022-07-22T16:58:58-04:00,2022-07-22,2nd-Quarter Earnings Results Could Impact Drug Company Shares,"The second-quarter earnings season is upon us, and the news coming out of several members of Big Pharma could potentially shake up their share prices. Beyond that, several unknowns could impact top-tier drug companies in the second half, including interest rates, federal drug pricing actions and scrutiny by the Federal Trade Commission.",gurufocus.com,https://www.gurufocus.com/news/1833469/2ndquarter-earnings-results-could-impact-drug-company-shares,https://images.financialmodelingprep.com/news/2ndquarter-earnings-results-could-impact-drug-company-shares-20220722.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-25 14:01:53,2022-07-25T14:01:53-04:00,2022-07-25,10 Best Low-Volatility Stocks to Buy Now,"The stock market is suffering a turbulent 2022 so far – and with inflation still running at a 40-year high, the Federal Reserve locked in a significant rate-hiking cycle and midterm elections just months away, it's likely the volatility is going to remain for the time being. Investors looking for a smoother market ride should consider buying low-volatility stocks as a way to manage risk.",kiplinger.com,https://www.kiplinger.com/investing/stocks/604969/best-low-volatility-stocks-to-buy-now,https://images.financialmodelingprep.com/news/10-best-lowvolatility-stocks-to-buy-now-20220725.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-27 05:55:00,2022-07-27T05:55:00-04:00,2022-07-27,Better Dividend Stock: Pfizer or Eli Lilly?,"Both stocks could be winners for long-term investors, but one gets the nod when it comes to dividends.",fool.com,https://www.fool.com/investing/2022/07/27/better-dividend-stock-pfizer-or-eli-lilly/,https://images.financialmodelingprep.com/news/better-dividend-stock-pfizer-or-eli-lilly-20220727.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-07-28 11:47:14,2022-07-28T11:47:14-04:00,2022-07-28,Earnings Preview: Eli Lilly (LLY) Q2 Earnings Expected to Decline,Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,zacks.com,https://www.zacks.com/stock/news/1959786/earnings-preview-eli-lilly-lly-q2-earnings-expected-to-decline,https://images.financialmodelingprep.com/news/earnings-preview-eli-lilly-lly-q2-earnings-expected-to-20220728.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-01 13:11:03,2022-08-01T13:11:03-04:00,2022-08-01,"Watch These Leaders With Earnings Due, Buy Zones In Focus","With earnings due, IBD Leaderboard stocks like Eli Lilly, Vertex and Ollie's test bases, breakouts and buy zones. The post Watch These Leaders With Earnings Due, Buy Zones In Focus appeared first on Investor's Business Daily.",investors.com,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/lnth-vrtx-lly-olli-stock-among-leaderboard-names-showing-strength-ahead-of-earnings/,https://images.financialmodelingprep.com/news/watch-these-leaders-with-earnings-due-buy-zones-in-20220801.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 16:40:05,2022-08-04T16:40:05-04:00,2022-08-04,Eli Lilly and Company (LLY) CEO Dave Ricks on Q2 2022 Results - Earnings Call Transcript,"Eli Lilly and Company (NYSE:LLY ) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President of Investor Relations Dave Ricks - Chair & Chief Executive Officer Anat Ashkenazi - Chief Financial Officer Dan Skovronsky - Chief Scientific Officer & Chief Medical Officer Mike Mason - President of Lilly Diabetes Ilya Yuffa - President of Lilly International Jake Van Naarden - Chief Executive Officer, Loxo Oncology, Lilly & President, Lilly Oncology Conference Call Participants Geoff Meacham - Bank of America Chris Schott - JPMorgan Seamus Fernandez - Guggenheim Louise Chen - Cantor Terence Flynn - Morgan Stanley Steve Scala - Cowen Andrew Baum - Citi Kerry Holford - Berenberg Robin Kinesis - Tuas Securities Colin Bristow - UBS Operator And ladies and gentlemen, thank you for standing by. Welcome to the Lilly Q2 2022 Earnings Conference Call.",seekingalpha.com,https://seekingalpha.com/article/4529909-eli-lilly-and-company-lly-ceo-dave-ricks-on-q2-2022-results-earnings-call-transcript,https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-ceo-dave-ricks-on-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 15:04:04,2022-08-04T15:04:04-04:00,2022-08-04,"Eli Lilly (LLY) Misses on Q1 Earnings, Lowers Earnings Guidance",Eli Lilly's (LLY) earnings and sales miss second-quarter estimates. The company lowers its earnings outlook for 2022.,zacks.com,https://www.zacks.com/stock/news/1964191/eli-lilly-lly-misses-on-q1-earnings-lowers-earnings-guidance,https://images.financialmodelingprep.com/news/eli-lilly-lly-misses-on-q1-earnings-lowers-earnings-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 12:10:13,2022-08-04T12:10:13-04:00,2022-08-04,Eli Lilly Q2 results: its Alzheimer's drug could be ‘the biggest drug in history',Shares of Eli Lilly & Co (NYSE: LLY) are in the red this morning after the pharmaceutical giant reported weaker-than-expected results for its fiscal second quarter. Key takeaways from Eli Lilly Q2 results Net income printed at $952.5 million versus the year-ago $1.39 billion Per-share earnings of $1.05 were well below last year's $1.,invezz.com,https://invezz.com/news/2022/08/04/jim-cramer-discusses-eli-lilly-q2-results-on-cnbc/,https://images.financialmodelingprep.com/news/eli-lilly-q2-results-its-alzheimers-drug-could-be-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 09:52:00,2022-08-04T09:52:00-04:00,2022-08-04,Lilly Updates Conference Call Start Time for Second-Quarter 2022 Financial Results,"INDIANAPOLIS , Aug. 4, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will now conduct its second-quarter 2022 financial results investor conference call today at 10 a.m. Eastern time due to third-party technical difficulties.",prnewswire.com,https://www.prnewswire.com/news-releases/lilly-updates-conference-call-start-time-for-second-quarter-2022-financial-results-301600105.html,https://images.financialmodelingprep.com/news/lilly-updates-conference-call-start-time-for-secondquarter-2022-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 09:02:15,2022-08-04T09:02:15-04:00,2022-08-04,Eli Lilly (LLY) Lags Q2 Earnings and Revenue Estimates,"Lilly (LLY) delivered earnings and revenue surprises of -30.56% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?",zacks.com,https://www.zacks.com/stock/news/1963636/eli-lilly-lly-lags-q2-earnings-and-revenue-estimates,https://images.financialmodelingprep.com/news/eli-lilly-lly-lags-q2-earnings-and-revenue-estimates-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 08:55:07,2022-08-04T08:55:07-04:00,2022-08-04,Eli Lilly Slashes Guidance After 'Significantly' Missing Quarterly Estimates; Shares Dive,"Eli Lilly missed second-quarter expectations and slashed its full-year outlook Thursday, leading LLY stock to crumble. The post Eli Lilly Slashes Guidance After 'Significantly' Missing Quarterly Estimates; Shares Dive appeared first on Investor's Business Daily.",investors.com,https://www.investors.com/news/technology/lly-stock-eli-lilly-earnings-q2-2022/,https://images.financialmodelingprep.com/news/eli-lilly-slashes-guidance-after-significantly-missing-quarterly-estimates-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 07:21:31,2022-08-04T07:21:31-04:00,2022-08-04,Eli Lilly stock falls 3% after Q2 top and bottom line results miss Wall Street's forecast,"Eli Lilly & Co. LLY, -1.99% shares fell 3.6% in pre-market trading on Thursday after the company reported second-quarter results that came in below Wall Street's forecast. The company's stock ended Wednesday's session down 2% at $313.83.",marketwatch.com,https://www.marketwatch.com/story/eli-lilly-stock-falls-3-after-q2-top-and-bottom-line-results-miss-wall-streets-forecast-2022-08-04,https://images.financialmodelingprep.com/news/eli-lilly-stock-falls-3-after-q2-top-and-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 06:31:00,2022-08-04T06:31:00-04:00,2022-08-04,Eli Lilly quarterly profit falls 31% on diabetes drug weakness,"Eli Lilly and Co reported a 31% fall in quarterly profit on Thursday, hurt by lower prices of diabetes drug Humalog and Insulin Lispro injection.",reuters.com,https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-quarterly-profit-falls-31-diabetes-drug-weakness-2022-08-04/,https://images.financialmodelingprep.com/news/eli-lilly-quarterly-profit-falls-31-on-diabetes-drug-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-04 06:25:00,2022-08-04T06:25:00-04:00,2022-08-04,"Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements","Lilly's revenue in Q2 2022 decreased 4%. On a constant currency basis, revenue decreased 1% as lower realized prices and lower Alimta revenue following the entry of generics more than offset volume growth from key growth products.",prnewswire.com,https://www.prnewswire.com/news-releases/lilly-reports-second-quarter-financial-results-highlights-momentum-of-new-medicines-and-pipeline-advancements-301599552.html,https://images.financialmodelingprep.com/news/lilly-reports-secondquarter-financial-results-highlights-momentum-of-new-20220804.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-05 16:41:10,2022-08-05T16:41:10-04:00,2022-08-05,"Following The Q2 Report, Eli Lilly Is A Hold On Valuation","Eli Lilly reported its Q2 results on Thursday, showing a revenue decline. Shares of Eli Lilly are trading for almost 40 times forward earnings, much higher than most tech companies.",seekingalpha.com,https://seekingalpha.com/article/4530414-following-the-q2-report-eli-lilly-is-a-hold-on-valuation,https://images.financialmodelingprep.com/news/following-the-q2-report-eli-lilly-is-a-hold-20220805.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-05 13:52:26,2022-08-05T13:52:26-04:00,2022-08-05,7 Long-Term Stocks to Buy and Hold Until 2023,"While stocks are still in bear market mode, and may have yet to reach a bottom, now is a great time to consider long-term stocks to buy and hold. As uncertainty continues to run high, plenty of high-quality stocks continue to be “on sale.",investorplace.com,https://investorplace.com/long-term-stocks-to-buy-and-hold/,https://images.financialmodelingprep.com/news/7-longterm-stocks-to-buy-and-hold-until-2023-20221018.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-08 06:45:00,2022-08-08T06:45:00-04:00,2022-08-08,"Lilly's Taltz® (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce Injection Site Pain for Improved Patient Experience","Since the medicine's first approval in 2016, nearly 130,000 people in the U.S. have been treated with Taltz INDIANAPOLIS , Aug. 8, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the availability of a new, citrate-free formulation of Taltz® (ixekizumab) injection 80 mg/mL. The new formulation, which was recently approved by The U.S. Food and Drug Administration in May 2022, includes the same active ingredient as the original formulation.",prnewswire.com,https://www.prnewswire.com/news-releases/lillys-taltz-ixekizumab-now-available-in-new-citrate-free-formulation-to-reduce-injection-site-pain-for-improved-patient-experience-301601067.html,https://images.financialmodelingprep.com/news/lillys-taltz-ixekizumab-now-available-in-new-citratefree-formulation-20220808.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-09 14:38:38,2022-08-09T14:38:38-04:00,2022-08-09,Eli Lilly Hits Some Bumps in the Road,"Hit by a spate of bad news, Eli Lilly and Co. ( LLY , Financial) has lost nearly 8% of its market value since July 28. Is it time for investors to join those bailing on the stock or jump in on the dip?",gurufocus.com,https://www.gurufocus.com/news/1845907/eli-lilly-hits-some-bumps-in-the-road,https://images.financialmodelingprep.com/news/eli-lilly-hits-some-bumps-in-the-road-20220809.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-11 18:12:11,2022-08-11T18:12:11-04:00,2022-08-11,Ken Fisher's Top 5 Trades in the 2nd Quarter,"Ken Fisher (Trades, Portfolio), CEO and chief investment officer of Fisher Investments, disclosed in a regulatory filing that his firm's top five trades during the second quarter included boosts to its holdings in Johnson & Johnson ( JNJ , Financial), Apple Inc. ( AAPL , Financial) and Microsoft ( MSFT , Financial) and reductions to its positions in Eli Lily & Co. ( LLY , Financial) and Adobe Inc. ( ADBE , Financial).",gurufocus.com,https://www.gurufocus.com/news/1847913/ken-fishers-top-5-trades-in-the-2nd-quarter,https://images.financialmodelingprep.com/news/ken-fishers-top-5-trades-in-the-2nd-quarter-20220811.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-11 08:30:00,2022-08-11T08:30:00-04:00,2022-08-11,Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Officer for Loxo@Lilly,"- Stephen Fry to retire at the end of 2022 - Eric Dozier named Senior Vice President, Human Resources and Diversity - Winselow Tucker to join Lilly as Senior Vice President and Chief Commercial Officer for Loxo@Lilly INDIANAPOLIS , Aug. 11, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the upcoming retirement of one executive committee member, the naming of his successor, and the hiring of a new chief commercial officer for Loxo@Lilly. After more than 35 years at Lilly, Stephen Fry, senior vice president, human resources and diversity, will retire at the end of 2022.",prnewswire.com,https://www.prnewswire.com/news-releases/lilly-announces-leadership-transition-in-human-resources-and-new-chief-commercial-officer-for-loxolilly-301603855.html,https://images.financialmodelingprep.com/news/lilly-announces-leadership-transition-in-human-resources-and-new-20220811.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-13 06:11:00,2022-08-13T06:11:00-04:00,2022-08-13,3 Stocks to Buy and Hold Forever,These stocks are keepers.,fool.com,https://www.fool.com/investing/2022/08/13/3-stocks-to-buy-and-hold-forever/,https://images.financialmodelingprep.com/news/3-stocks-to-buy-and-hold-forever-20220813.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-16 10:15:00,2022-08-16T10:15:00-04:00,2022-08-16,This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?,"More than two years into the pandemic, hospitalized patients with severe cases may get a game-changing treatment.",fool.com,https://www.fool.com/investing/2022/08/16/this-growth-stock-has-soared-over-200-year-to-date/,https://images.financialmodelingprep.com/news/this-growth-stock-has-soared-over-200-year-to-20220816.jpg
LLY,2022-08-04,2022-07-21,2022-08-18,LLY,,2022-08-17 10:00:00,2022-08-17T10:00:00-04:00,2022-08-17,How Eli Lilly Is Thinning Out the Competition,The company sees good market signals from its recently launched potential blockbuster drug.,fool.com,https://www.fool.com/investing/2022/08/17/how-eli-lilly-is-thinning-out-the-competition/,https://images.financialmodelingprep.com/news/how-eli-lilly-is-thinning-out-the-competition-20220817.jpg
